Increasing of PCOs among Young Females | ||||
The Egyptian Journal of Hospital Medicine | ||||
Article 13, Volume 69, Issue 5, October 2017, Page 2442-2447 PDF (290.1 K) | ||||
Document Type: Original Article | ||||
DOI: 10.12816/0041691 | ||||
View on SCiNiTO | ||||
Authors | ||||
Koloud Ateeq Alharbi 1; Mohammed Meshal AlShathri2; Sajidah Alah Alshnqyta3; Safaa Mahmood Al-Hasani4; Mazin Ali Aaad Almosa5; Abdulrahman Mohammed Aljowair6; Osama Mohammed Alkhalifah7; Lina Emad Nouraldien1; Abdulrahman Omar Mansy8; Hadeel Lowthan Alshammari9 | ||||
1Ibn Sina National College For Medical Studies, Jeddah, Saudi Arabia | ||||
2rince Sattam Bin Abdulaziz University | ||||
3Taibah University, Al Madinah Al Munawarah , Saudi Arabia | ||||
4Batterjee Medical College For Science And Technology, Jeddah, Saudi Arabia | ||||
5King Khalid University, Abha, Saudi Arabia | ||||
6Prince Sattam Bin Abdulaziz University, Al-Kharj, Saudi Arabia | ||||
7Mansoura University, Mansoura , Egypt | ||||
8Taif University, Altaif, Saudi Arabia, | ||||
9Immam Abdulrahman Bin Faisal University, Al Dammam, Saudi Arabia | ||||
Abstract | ||||
Polycystic ovary syndrome (PCOS) is a typical heterogeneous endocrine disorder characterized by irregular menses, polycystic ovaries, and hyperandrogenism. The pervasiveness of PCOS differs relying upon which criteria are utilized to make the diagnosis. Clinical manifestations incorporate oligomenorrhea or amenorrhea, hirsutism, and normally infertility. Risk factors for PCOS in adult women incorporates type I diabetes, type II diabetes, and gestational diabetes. Insulin resistance influences 50%–70% of women with PCOS prompting various comorbidities containing metabolic syndrome, dyslipidemia, diabetes, glucose intolerance, and hypertension. Studies demonstrate that women with PCOS will probably have expanded coronary artery calcium scores and increased carotid intima-media thickness. Mental health disorders comprising anxiety, depression, binge eating disorder and bipolar disorder similarly occur more often in women with PCOS. Weight loss advances menstrual irregularities, symptoms of androgen excess, and infertility. Management of clinical manifestations of PCOS comprises oral contraceptives for menstrual irregularities and hirsutism. Spironolactone and finasteride are used to treat symptoms of androgen excess. Treatment options for infertility include clomiphene, gonadotropins, laparoscopic ovarian drilling, and assisted reproductive technology. Appropriate diagnosis and administration of PCOS is crucial to address patient concerns yet additionally to anticipate future metabolic, endocrine, psychiatric, and cardiovascular complications. | ||||
Keywords | ||||
polycystic ovary syndrome; Diagnosis; Treatment; surgical intervention | ||||
Statistics Article View: 161 PDF Download: 382 |
||||